INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 289 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2024$970
+13.6%
90.0%0.00%
Q1 2024$854
+2.9%
90.0%0.00%
Q4 2023$830
+83.6%
90.0%0.00%
Q3 2023$452
+43.0%
9
+80.0%
0.00%
Q2 2023$316
+40.4%
50.0%0.00%
Q1 2023$225
+2.7%
50.0%0.00%
Q4 2022$21950.0%0.00%
Q3 2022$05
-44.4%
0.00%
Q2 2022$0
-100.0%
90.0%0.00%
Q1 2022$1,0000.0%90.0%0.00%
Q4 2021$1,0000.0%90.0%0.00%
Q3 2021$1,0000.0%9
-40.0%
0.00%
Q2 2021$1,0000.0%150.0%0.00%
Q1 2021$1,000
-66.7%
15
-37.5%
0.00%
-100.0%
Q4 2020$3,000
+50.0%
24
-4.0%
0.00%
Q3 2020$2,000
+100.0%
25
+38.9%
0.00%
Q2 2020$1,0000.0%18
-25.0%
0.00%
Q1 2020$1,000
-50.0%
240.0%0.00%
Q4 2019$2,0000.0%240.0%0.00%
Q3 2019$2,0000.0%24
-4.0%
0.00%
Q2 2019$2,0000.0%250.0%0.00%
Q1 2019$2,000
+100.0%
250.0%0.00%
Q4 2018$1,000
-50.0%
250.0%0.00%
Q3 2018$2,000250.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 559,381$41,098,00015.69%
Casdin Capital, LLC 940,000$69,061,800,0007.15%
Ghost Tree Capital, LLC 325,000$23,878,0006.08%
CADIAN CAPITAL MANAGEMENT, LP 1,418,704$104,232,0004.96%
DAFNA Capital Management LLC 123,218$9,053,0003.40%
BVF INC/IL 437,565$32,148,0003.38%
Opaleye Management Inc. 105,000$7,714,0002.79%
Cormorant Asset Management, LP 493,000$36,221,0002.20%
Novo Holdings A/S 170,667$12,539,0002.15%
Artal Group S.A. 600,000$44,082,0001.77%
View complete list of BLUEPRINT MEDICINES CORP shareholders